Correction to: Journal of Cancer Research and Clinical Oncology (2020) 146:3207–3214 https://doi.org/10.1007/s00432-020-03363-y

In the original article published, the figures 3 and 4 are published incorrectly. The correct Figs. 3 and 4 are as given below.

Fig. 3
figure 3

Time of occurrence of HCC in a group with elevated ascetic Calprotectin compared to a group with normal value

Fig. 4
figure 4

Receiver operating characteristics analysis of the ascitic Calprotectin to identify risk of occurrence of HCC

The original article has been corrected.